open access

Vol 16, No 1 (2014)
Review articles
Published online: 2014-11-13
Get Citation

Usefulness of testing for the prevalence of systemic inflammatory response syndrome (SIRS) in clinical practice

Grzegorz Hadasik, Karolina Hadasik, Agnieszka Święszek
Chirurgia Polska 2014;16(1):12-19.

open access

Vol 16, No 1 (2014)
Review articles
Published online: 2014-11-13

Abstract

Systemic inflammatory response syndrome (SIRS) was first described in 1991 as a group of syndromes which are easy to define clinically. SIRS should not be perceived as a diagnosis, but rather the clinical picture of changes in the levels of acute phase mediators, or a state of imbalance of the whole body in response to trauma, e.g. surgical trauma. For nearly twenty-five years subsequent generations of physicians have been trying to answer the question whether diagnosing SIRS in a patient makes sense, and if so, why. A number of published studies contain the evidence that the diagnosis of SIRS is associated with the following factors: development of single or multiple organ failure; increase in the incidence of deaths; longer hospitalization; longer stay in the Intensive Care Unit; development of infection, sepsis or severe sepsis. The overall conclusion is that the primary advantage of using SIRS as a prognostic scale is the ease and speed of testing for its criteria, and virtually no related costs. It has been repeatedly proven that it is in good correlation with the much more expensive and difficult prognostic scales, such as APACHE II, APACHE III, SAPS, ISS or MODS. Assessment of the criteria for systemic inflammatory response syndrome, feasible at the patient’s bedside, allows the physician to perform a swift selection of patients and recognize those with a higher risk of serious complications, thus introducing appropriate therapy, increasing vigilance and possibly performing subsequent extended laboratory tests.

Abstract

Systemic inflammatory response syndrome (SIRS) was first described in 1991 as a group of syndromes which are easy to define clinically. SIRS should not be perceived as a diagnosis, but rather the clinical picture of changes in the levels of acute phase mediators, or a state of imbalance of the whole body in response to trauma, e.g. surgical trauma. For nearly twenty-five years subsequent generations of physicians have been trying to answer the question whether diagnosing SIRS in a patient makes sense, and if so, why. A number of published studies contain the evidence that the diagnosis of SIRS is associated with the following factors: development of single or multiple organ failure; increase in the incidence of deaths; longer hospitalization; longer stay in the Intensive Care Unit; development of infection, sepsis or severe sepsis. The overall conclusion is that the primary advantage of using SIRS as a prognostic scale is the ease and speed of testing for its criteria, and virtually no related costs. It has been repeatedly proven that it is in good correlation with the much more expensive and difficult prognostic scales, such as APACHE II, APACHE III, SAPS, ISS or MODS. Assessment of the criteria for systemic inflammatory response syndrome, feasible at the patient’s bedside, allows the physician to perform a swift selection of patients and recognize those with a higher risk of serious complications, thus introducing appropriate therapy, increasing vigilance and possibly performing subsequent extended laboratory tests.

Get Citation

Keywords

systemic inflammatory response syndrome, definition, pathophysiology, diagnostics

About this article
Title

Usefulness of testing for the prevalence of systemic inflammatory response syndrome (SIRS) in clinical practice

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 16, No 1 (2014)

Pages

12-19

Published online

2014-11-13

Bibliographic record

Chirurgia Polska 2014;16(1):12-19.

Keywords

systemic inflammatory response syndrome
definition
pathophysiology
diagnostics

Authors

Grzegorz Hadasik
Karolina Hadasik
Agnieszka Święszek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl